Filtered By:
Condition: Hemorrhagic Stroke
Infectious Disease: Coronavirus

This page shows you your search results in order of relevance. This is page number 15.

Order by Relevance | Date

Total 369 results found since Jan 2013.

Potential mechanisms of cerebrovascular diseases in COVID-19 patients
AbstractSince the outbreak of coronavirus disease 2019 (COVID-19) in 2019, it is gaining worldwide attention at the moment. Apart from respiratory manifestations, neurological dysfunction in COVID-19 patients, especially the occurrence of cerebrovascular diseases (CVD), has been intensively investigated. In this review, the effects of COVID-19 infection on CVD were summarized as follows: (I) angiotensin-converting enzyme 2 (ACE2) may be involved in the attack on vascular endothelial cells by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), leading to endothelial damage and increased subintimal inflammation, wh...
Source: Journal of NeuroVirology - February 3, 2021 Category: Neurology Source Type: research

Neurologic Emergencies during the Coronavirus Disease 2019 Pandemic
Although minor neurologic complications of coronavirus disease 2019 are common, life-threatening neurologic emergencies are rare. Acute ischemic stroke, intracerebral hemorrhage, venous sinus thrombosis, seizures, and posterior reversible encephalopathy syndrome have been described. Hospitals have seen significant changes in the volume of patients presenting with neurologic emergencies. We review what has thus far been published about the intersection of coronavirus disease 2019 and neurologic emergencies with particular attention to cerebrovascular disease and seizure. Considerations in managing the acute presentations of...
Source: Neurologic Clinics - March 26, 2021 Category: Neurology Authors: Julie G. Shulman, Thomas Ford, Anna M. Cervantes-Arslanian Source Type: research

COVID-19 patients who suffer hemorrhagic strokes are up to 2.8 times more likely to die
A new study from the University of Utah Health has found that coronavirus patients who suffer hemorrhagic strokes are between 2.5 and 2.8 times more likely to die than non-COVID stroke patients.
Source: the Mail online | Health - April 14, 2021 Category: Consumer Health News Source Type: news

Viruses, Vol. 13, Pages 700: Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms
id J Alzahrani Aristóteles Góes-Neto Vasco Azevedo Preetam Ghosh Debmalya Barh The COVID-19 pandemic has infected millions worldwide, leaving a global burden for long-term care of COVID-19 survivors. It is thus imperative to study post-COVID (i.e., short-term) and long-COVID (i.e., long-term) effects, specifically as local and systemic pathophysiological outcomes of other coronavirus-related diseases (such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS)) were well-cataloged. We conducted a comprehensive review of adverse post-COVID health outcomes and potential long-COV...
Source: Viruses - April 18, 2021 Category: Virology Authors: Bruno Silva Silva Andrade S érgio Siqueira Wagner Rodrigues de Assis de Assis Soares Fernanda de Souza de Souza Rangel Naiane Oliveira Santos Andria dos Santos dos Santos Freitas Priscila Ribeiro da Ribeiro da Silveira Sandeep Tiwari Khalid J Alzahrani A Tags: Review Source Type: research

Risk factors for intracerebral hemorrhage in patients with COVID-19
AbstractIntracerebral hemorrhage (ICH) can be a devastating complication of coronavirus disease (COVID-19). We aimed to assess risk factors associated with ICH in this population. We performed a retrospective cohort study of adult patients admitted to NYU Langone Health system between March 1 and April 27 2020 with a positive nasopharyngeal swab polymerase chain reaction test result and presence of primary nontraumatic intracranial hemorrhage or hemorrhagic conversion of ischemic stroke on neuroimaging. Patients with intracranial procedures, malignancy, or vascular malformation were excluded. We used regression models to e...
Source: Journal of Thrombosis and Thrombolysis - April 29, 2021 Category: Hematology Source Type: research

Neurologic Manifestations of COVID-19
Adv Exp Med Biol. 2021;1318:343-353. doi: 10.1007/978-3-030-63761-3_20.ABSTRACTNeurological manifestations of novel coronavirus disease (COVID-19) are reported to occur in as much as 37% of the affected patients. These manifestations range from headache and dizziness to altered mental status and consciousness, anosmia, ageusia, sensory disturbances, and stroke. The mechanisms by which the neurological symptoms arise are not yet determined but may either proceed as an indirect consequence of systemic hyperinflammation or result from the direct invasion of the virus to neural and glial cells. The neural invasion can explain ...
Source: Advances in Experimental Medicine and Biology - May 11, 2021 Category: Research Authors: Farnaz Delavari Farnaz Najmi Varzaneh Nima Rezaei Source Type: research

Neurological Injury in COVID-19 Patients Who Receive VV-ECMO Therapy: A Cohort Study
Both thrombotic and bleeding events have been implicated in the progression of Coronavirus disease 2019 (COVID-19).1,2 Such dysregulation of coagulation has been associated with poor prognosis.3,4 Neurologic sequelae, such as ischemic stroke and intracranial hemorrhage (ICH), have been reported in COVID-19 patients at rates of 0.9%-2.3% and 0.9%, respectively.5,6,7,8 Limited data exists on neurological events in COVID-19 patients in the intensive care unit (ICU) who require extracorporeal membrane oxygenation (ECMO) due to severe acute respiratory distress syndrome (ARDS).
Source: Journal of Cardiothoracic and Vascular Anesthesia - May 13, 2021 Category: Anesthesiology Authors: Nivedha V. Kannapadi, Meghana Jami, Lavienraj Premraj, Eric W. Etchill, Katherine Giuliano, Errol L. Bush, Bo Soo Kim, Stella Seal, Glenn Whitman, Sung-Min Cho Tags: Letter to the Editor Source Type: research

Neurologic Injury in Patients With COVID-19 Who Receive VV-ECMO Therapy: A Cohort Study
THROMBOTIC AND BLEEDING events have been implicated in the progression of coronavirus disease 2019 (COVID-19).1,2 This dysregulation of coagulation has been associated with poor prognoses.3,4 Neurologic sequelae, such as ischemic stroke and intracranial hemorrhage (ICH), have been reported in patients with COVID-19 at rates of 0.9%-to-2.3% and 0.9%, respectively.5,6,7,8 Limited data exist on neurologic events in patients with COVID-19 in the intensive care unit who require extracorporeal membrane oxygenation (ECMO) due to severe acute respiratory distress syndrome (ARDS).
Source: Journal of Cardiothoracic and Vascular Anesthesia - May 13, 2021 Category: Anesthesiology Authors: Nivedha V. Kannapadi, Meghana Jami, Lavienraj Premraj, Eric W. Etchill, Katherine Giuliano, Errol L. Bush, Bo Soo Kim, Stella Seal, Glenn Whitman, Sung-Min Cho Tags: Letters to the Editor Source Type: research

Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19
AbstractPatients with Coronavirus Disease-2019 (COVID ‐19) have haemostatic dysfunction and are at higher risk of thrombotic complications. Although age is a major risk factor for outcome impairment in COVID-19, its impact on coagulative patterns here is still unclear. We investigated the association of Endogenous Thrombin Potential (ETP) with thromb otic and haemorrhagic events according to different ages in patients admitted for COVID-19. A total of 27 patients with COVID‐19-related pneumonia, without need for intensive care unit admission or mechanical ventilation at hospital presentation, and 24 controls with non-C...
Source: Journal of Thrombosis and Thrombolysis - June 10, 2021 Category: Hematology Source Type: research

Brain and Lung Imaging Correlation in Patients with COVID-19: Could the Severity of Lung Disease Reflect the Prevalence of Acute Abnormalities on Neuroimaging? A Global Multicenter Observational Study ADULT BRAIN
CONCLUSIONS: The CT lung disease severity score may be predictive of acute abnormalities on neuroimaging in patients with COVID-19 with neurologic manifestations. This can be used as a predictive tool in patient management to improve clinical outcome.
Source: American Journal of Neuroradiology - June 10, 2021 Category: Radiology Authors: Mahammedi, A., Ramos, A., Bargallo, N., Gaskill, M., Kapur, S., Saba, L., Carrete, H., Sengupta, S., Salvador, E., Hilario, A., Revilla, Y., Sanchez, M., Perez-Nunez, M., Bachir, S., Zhang, B., Oleaga, L., Sergio, J., Koren, L., Martin-Medina, P., Wang, L Tags: ADULT BRAIN Source Type: research

COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation.
Novel coronavirus disease 2019 (COVID-19) has caused confirmed infections in more than 30 million Americans by April 2021, and 130 million worldwide, with a case fatality rate of up to 2-10% (https://ourworldindata.org/coronavirus/). It can cause ischemic and hemorrhagic strokes secondary to coagulopathy and endothelial injury.1 These same factors play a role in Cerebral Cavernous Malformation (CCM), a uncommon hemorrhagic neurovascular disease characterized by grossly dilated vascular “caverns” lined by a single layer of dysfunctional endothelium.
Source: Journal of Stroke and Cerebrovascular Diseases - September 7, 2021 Category: Neurology Authors: Abdallah Shkoukani, Abhinav Srinath, Agnieszka Stadnik, Romuald Girard, Robert Shenkar, Adrienne Sheline, Kristen Dahlem, Cornelia Lee, Kelly Flemming, Issam A. Awad Tags: RESEARCH LETTER Source Type: research

A case-based systematic review on the SARS-COVID-2-associated cerebrovascular diseases and the possible virus routes of entry
AbstractSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sparked a global pandemic that continues to affect various facets of human existence. Many sources reported virus-induced acute cerebrovascular disorders. Systematically, this paper reviews the case studies of COVID-19-related acute cerebrovascular diseases such as ischaemic stroke, intracerebral hemorrhage, and cerebral sinus thrombosis. We also spoke about how SARS-CoV-2 can infect the brain and trigger the aforementioned disorders. We stated that SARS-CoV-2 neuroinvasion and BBB dysfunction could cause the observed disorders; however, further research ...
Source: Journal of NeuroVirology - September 21, 2021 Category: Neurology Source Type: research

Delays in Intracerebral Hemorrhage Management Is Associated with Hematoma Expansion and Worse Outcomes: Changes in COVID-19 Era
CONCLUSION: During the COVID-19 era, delays in management of ICH was associated with hematoma expansion and worse outcomes.PMID:34558870 | DOI:10.3349/ymj.2021.62.10.911
Source: Yonsei Medical Journal - September 24, 2021 Category: Universities & Medical Training Authors: Hyun Jin Han Keun Young Park Junhyung Kim Woosung Lee Yun Ho Lee Chang Ki Jang Kwang-Chun Cho Sang Kyu Park Joonho Chung Young Sub Kwon Yong Bae Kim Jae Whan Lee So Yeon Kim Source Type: research

Hospital admissions of acute cerebrovascular diseases during and after the first wave of the COVID-19 pandemic: a state-wide experience from Austria
AbstractWe investigated hospital admission rates for the entire spectrum of acute cerebrovascular diseases and of recanalization treatments for ischaemic stroke (IS) in the Austrian federal state of Styria during and also after the first coronavirus disease 2019 (COVID-19) wave. We retrospectively identified all patients with transient ischaemic attack (TIA), IS and non-traumatic intracranial haemorrhage (ICH; including intracerebral, subdural and subarachnoid bleeding types) admitted to one of the 11 public hospitals in Styria (covering  >  95% of inhospital cerebrovascular events in this region). Information was e...
Source: Journal of Neurology - September 27, 2021 Category: Neurology Source Type: research